Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study will examine the effects of low-dose naltrexone (LDN) on children with autistic spectrum disorders. The investigators hope to show a positive effect on social functioning and language.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hadassah Medical Organization
• Collaborator: Jerusalem Institute for Child Development
• Treatments: Naltrexone

Criteria

Inclusion Criteria:

• Diagnosis of PDD